2018
DOI: 10.1016/j.jep.2018.02.036
|View full text |Cite
|
Sign up to set email alerts
|

Acetone fraction from Sechium edule (Jacq.) S.w. edible roots exhibits anti-endothelial dysfunction activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 59 publications
1
10
0
Order By: Relevance
“…However, the root had not been studied as a therapeutic tool in hepatic diseases. In a previous work by our research group, an acetone fraction of S. edule root (rSe-FA) was found to be effective in controlling ED induced in mice by chronic administration of a sub-effective dose of ANGII; in that study, ANGII was found to induce morphological changes in the liver similar to those of NASH (Trejo-Moreno et al, 2021), and that administration of this fraction prevented such damage (Trejo-Moreno et al, 2018). Moreover, the fraction was rich in cinnamic and coumaric acids, whose antioxidant (Shen et al, 2019;Anlar, 2020) and anti-inflammatory properties (Karatas et al, 2020)…”
Section: Introductionmentioning
confidence: 89%
See 1 more Smart Citation
“…However, the root had not been studied as a therapeutic tool in hepatic diseases. In a previous work by our research group, an acetone fraction of S. edule root (rSe-FA) was found to be effective in controlling ED induced in mice by chronic administration of a sub-effective dose of ANGII; in that study, ANGII was found to induce morphological changes in the liver similar to those of NASH (Trejo-Moreno et al, 2021), and that administration of this fraction prevented such damage (Trejo-Moreno et al, 2018). Moreover, the fraction was rich in cinnamic and coumaric acids, whose antioxidant (Shen et al, 2019;Anlar, 2020) and anti-inflammatory properties (Karatas et al, 2020)…”
Section: Introductionmentioning
confidence: 89%
“…The remaining three groups were treated with ANGII (Sigma, St. Louis, MO, United States) i. p, 0.01 μg/kg/day (ANGII) (Trejo-Moreno et al, 2021), for 11 weeks, either alone or coadministered p. o. with Losartan (LOS) (Cozaar ® , Merck Sharp & Dohme, Kenilworth, NJ, United States) at a dose of 10 mg/kg diluted in 0.2% carboxymethylcellulose (CMC, Maquimex, Mexico) (Bastaki, et al, 2018) or rSe-HA diluted in water, at a dose of 11 mg/kg, for 11 weeks. Both treatment time and the dose administered were based on data previously reported by Trejo-Moreno et al (2018). Dose calculation was based on the concentration of cinnamic acid in the HA extract, which in turn was calculated based on the concentration of the same molecule in the acetone extract used by Trejo-Moreno et al (2018).…”
Section: Animals and Experimental Groupsmentioning
confidence: 99%
“…This plant has been used for the treatment of renal disease, obesity, and arteriosclerosis [1]. There are several documents that reported about chayote phytochemical investigation [1][2][3][4][5]. There are various groups of secondary metabolites were produced, including fatty acid derivatives [2], flavonoids [1,3,4], and organic acids [5].…”
Section: Introductionmentioning
confidence: 99%
“…There are several documents that reported about chayote phytochemical investigation [1][2][3][4][5]. There are various groups of secondary metabolites were produced, including fatty acid derivatives [2], flavonoids [1,3,4], and organic acids [5]. Furthermore, these compounds exhibited pharmaceutical activities such as anti-endothelial dysfunction activity [5] and lipid accumulation inhibition [4].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation